Study Shows Testosterone Treatment Beneficial for Men Diagnosed With Type II Diabetes
Men suffering from Type 2 diabetes can reduce the negative impacts of the disease by going for testosterone treatment. This was discovered after a lengthy study that was aimed at showing the relationship between inflammation caused by Type II diabetes and insulin resistance.
According to researchers from the University Of Buffalo, New York, there is a correlation between insulin sensitivity and levels of testosterone where higher testosterone levels seem to reduce insulin sensitivity. The researchers closely monitored several men who had been diagnosed with the insulin-related condition and put one group under testosterone treatment while another was subjected to placebo.
Led by Paresh Dandona, MD, PhD, SUNY Distinguished Professor, senior author and chief of diabetes, metabolism, and endocrinology at University of Buffallo’s Department of Medicine, researchers found that men who had low levels of testosterone also had low levels of insulin sensitivity. After undergoing testosterone treatment, the patient’s insulin sensitivity declined as the testosterone levels increased.
The study showed that men who were under treatment experienced decline in insulation sensitivity to a tune of 36% while there was no change in the other men under placebo. Higher production and absorption of glucose is the main issue in people affected by Type II diabetes, but by increasing the level of testosterone, low amount of glucose is consumed by the body while metabolism increases leading to better health. This is what the study undertaken by Dandona and his fellow colleagues revealed.
Further revelations showed that increased level of testosterone encouraged the growth of muscles while reducing the amount of body fat. The weight of the men under treatment was the same at the start and after the end of the study indicating that muscles had replaced body fat.
This isn’t the first time researchers from the University of Buffalo, New York, have performed such kind of studies. In 2004 and while focus on the correlation between testosterone and insulin sensitivity, Dandona and his team published a report that showed men with low testosterone are more likely to suffer from insulin sensitivity which is symbolic with Type 2 diabetes. The study also showed that obese men were at a disadvantage in regard to low testosterone and high chances of being affected by the disease.
The general consensus is testosterone acts as a sensitizer for insulin and can therefore help people who suffer from insulin-related diseases such as Type 2 diabetes deal with the condition. Focus will most likely shift to improving testosterone treatment as a way of dealing with diabetes especially in men.